MediniceWAR:ICE -4.53%24 FCF Yield % is -1.76 as of Jun. 30, 2026. GuruFocus rates WAR:ICE with a GF Score™ of 24/100 and a GF Value™ of zł0.99 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 854 Medical Devices & Instruments companies, Medinice ranks worse than 55.85% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Medinice's Trailing 12-Month Free Cash Flow is zł-11.74 Mil, and Market Cap is zł664.92 Mil. Therefore, Medinice's FCF Yield % for today is -1.76%.
The historical rank and industry rank for Medinice's FCF Yield % or its related term are showing as below:
WAR:ICE'
s FCF Yield % Range Over the Past 10 Years
Min: -23.47 Med: -7.74 Max: -1.56
Current: -1.76
During the past 10 years, the highest FCF Yield % of Medinice was -1.56%. The lowest was -23.47%. And the median was -7.74%.
WAR:ICE's FCF Yield % is ranked worse than 55.85% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: -0.385
vs WAR:ICE: -1.76
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Medinice FCF Yield % Related Terms
Medinice FCF Yield % Historical Data
* Premium members only.
The historical data trend for Medinice's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medinice's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medinice FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medinice's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Medinice's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medinice (WAR:ICE) has a FCF Yield % of -1.76 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medinice and its competitors. According to the industry distribution chart, Medinice ranks #477 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 55.9%.
Is Medinice's FCF Yield % too high?
Medinice's current FCF Yield % is -1.76. Based on the distribution chart, Medinice ranks #477 out of 854 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Medinice has a GF Score™ of 24/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medinice's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medinice ranks #477 out of 854 companies for FCF Yield %. This places Medinice in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medinice and its competitors. Medinice's current FCF Yield % is -1.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinice stock overvalued right now?
Based on GuruFocus' analysis, Medinice (WAR:ICE) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.99, compared to a current price of zł71.60 — trading 7132.3% above its estimated fair value. The current FCF Yield % is -1.76. Medinice's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Medinice (WAR:ICE), the current FCF Yield % is -1.76 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medinice (WAR:ICE) Overvalued in 2026?
Based on GuruFocus' analysis, Medinice stock appears to be overvalued.
The current stock price of zł71.60 is trading 7132.3% above its estimated GF Value™ of zł0.99.
GuruFocus considers Medinice to be Significantly Overvalued.
Key valuation signals for WAR:ICE:
FCF Yield %: -1.76
GF Value™: zł0.99 vs. price of zł71.60 (7132.3% above fair value)
No single metric tells the full story. See the WAR:ICE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medinice SA is a Polish company operating in the MedTech industry. The company is engaged in creating, developing and commercializing solutions in the field of medicine, in particular, cardiology and cardio surgery. Its portfolio includes close around 12 projects including CathAIO, an electrode with universal diagnostic, electrophysiological, haemodinamic and biohemic functions and can be used for RF ablation; cryoapplicator, for minimally invasive cardiosurgical cryoablation; Med-iConsole allows to reduce the need to use multiple computer devices during electrophysiological treatment; Minimax and Pacepress.
24GF Score
Get the complete analysis for WAR:ICE
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:ICE has been successfully added to your 
